On December 30, 2021, Jim Sulat notified the board of directors of Arch Therapeutics, Inc. that he will resign as a member of the Board effective December 31, 2021. There are no disagreements of any kind between the Company and Mr. Sulat related to his resignation as a director or otherwise.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | +0.68% | +43.27% | -79.42% |
1st Jan change | Capi. | |
---|---|---|
-79.42% | 6.58M | |
+10.24% | 128B | |
-8.89% | 11.26B | |
+3.31% | 9.28B | |
+35.16% | 5.42B | |
-23.90% | 4.8B | |
+8.20% | 3.45B | |
-10.69% | 2.8B | |
-12.15% | 2.1B | |
-11.96% | 1.98B |
- Stock Market
- Equities
- ARTH Stock
- News Arch Therapeutics, Inc.
- Arch Therapeutics, Inc. Announces Resignation of Jim Sulat as Member of the Board